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Background: Smoking is the single most important health threat yet there is no consistency as to whether
non-smokers experience a compression of years lived with disability compared to (ex-)smokers. The objectives of
the manuscript are (1) to assess the effect of smoking on the average years lived without disability (Disability Free
Life Expectancy (DFLE)) and with disability (Disability Life Expectancy (DLE)) and (2) to estimate the extent to which
these effects are due to better survival or reduced disability in never smokers.
Methods: Data on disability and mortality were provided by the Belgian Health Interview Survey 1997 and 2001
and a 10 years mortality follow-up of the survey participants. Disability was defined as difficulties in activities of daily
living (ADL), in mobility, in continence or in sensory (vision, hearing) functions. Poisson and multinomial logistic
regression models were fitted to estimate the probabilities of death and the prevalence of disability by age, gender
and smoking status adjusted for socioeconomic position. The Sullivan method was used to estimate DFLE and DLE
at age 30. The contribution of mortality and of disability to smoking related differences in DFLE and DLE was
assessed using decomposition methods.
Results: Compared to never smokers, ex-smokers have a shorter life expectancy (LE) and DFLE but the number of years
lived with disability is somewhat larger. For both sexes, the higher disability prevalence is the main contributing
factor to the difference in DFLE and DLE. Smokers have a shorter LE, DFLE and DLE compared to never smokers.
Both higher mortality and higher disability prevalence contribute to the difference in DFLE, but mortality is more
important among males. Although both male and female smokers experience higher disability prevalence, their
higher mortality outweighs their disability disadvantage resulting in a shorter DLE.
Conclusion: Smoking kills and shortens both life without and life with disability. Smoking related disability can
however not be ignored, given its contribution to the excess years with disability especially in younger age
groups.
Keywords: Disability free life expectancy, Disability life expectancy, Life expectancy, Health expectancy, Disability,
Mortality, Smoking, Decomposition, BelgiumBackground
Smoking is without doubt the single most important
global cause of premature mortality. The current death
toll from direct and second hand tobacco smoking in
adults 30 years and over is estimated to be globally well
over 5.5 million each year [1]. While at present the
highest proportion of deaths attributable to tobacco are* Correspondence: hvanoyen@wiv-isp.be
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unless otherwise stated.in America and Europe, the largest proportions of
tobacco-related deaths in the coming decades is ex-
pected to occur in medium and low income countries
[2]. Smokers may lose up to one decade of life expect-
ancy [3,4]. However, prolonged cessation, when started
early enough, reduces the risk of mortality associated
with smoking by 90% or more [3-5] and hence greater
mortality benefits are observed among early quitters [6].
Implementation of evidence-based tobacco control mea-
sures, such as smoke-free air laws or taxation, contribute
to the avoidance of substantial numbers of prematureral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Van Oyen et al. BMC Public Health 2014, 14:723 Page 2 of 12
http://www.biomedcentral.com/1471-2458/14/723deaths [7]. Smoking has also been associated with the
incidence of chronic diseases, especially several cancers,
cardiovascular diseases, and lung disease [8-10], and
with the incidence of disability and poor health-related
quality of life [11,12].
Although non-smoking is related to a longer life and a
longer healthier life, there is no agreement in the literature
on whether smoking cessation also leads to fewer years
with morbidity. Some publications suggest that smoking
reduces both the duration of life free of and with diseases
and disability so that in the end, never smokers live the
same or even more years in ill-health [8,13-17]. Other au-
thors report that smokers have to endure in their shorter
life more years and a greater proportion of their life with
disability [18-20]. The first group of manuscripts suggests
the need to consider a trade-off between a longer life
and a longer life in ill-health [21], while the latter stud-
ies support the compression of morbidity theory that
can be reached through primordial and primary preven-
tion [22]. For public health policy, it is important to bet-
ter understand this discrepancy in current literature and
to better assess health gains or losses in relation to
smoke reducing interventions, specifically: “Is the gap
in duration of life in total and with or without disability,
between never smokers and ex- or current smokers, due
to differences in mortality and/or due to differences in
disability?”.
The objectives of the current manuscript are therefore
(1) to determine the effect of smoking on the duration
of life with and without disability and (2) to estimate the
contribution of the higher mortality and higher disability
associated with smoking to the difference in the years lived
with and without disability between smoking groups.
Methods
Data
To calculate Disability Free Life Expectancy (DFLE) and
Disability Life Expectancy (DLE) by smoking status two
sources of data are required. First, information is needed
about the mortality by smoking status. This information
was extracted from the mortality follow-up of the Belgian
Health Interview Surveys 1997 and 2001 (HIS 1997; HIS
2001) participants. The surveys were carried out by
Statistics Belgium and exempted by law from requiring
ethics approval. The process of obtaining mortality
follow-up information is regulated by the Belgian Com-
mission for the Protection of Privacy. After the approval
of the Commission, Statistics Belgium provided follow-up
data for the HIS 1997 and HIS 2001 participants until date
of death, date of emigration or until respectively 31/12/
2007 and 31/12/2010. Follow-up was obtained by indi-
vidual record linkage between the HIS and the National
Register, a public register with details of all registered
residents in Belgium, using the National IdentificationNumber. Statistics Belgium provided the list, including
the date of death, of the HIS 1997 and HIS 2001 partici-
pants who had died by the end of the follow-up period.
Second, information is needed about the prevalence of dis-
ability by smoking status. This information was extracted
from both surveys. The participants in these national
cross-sectional surveys were selected from the National
Register through a multistage stratified sample of the
Belgian population aged 15 years and older. Potential
participants were informed by an invitation letter with
leaflet and by the interviewer that the participation to
the survey is voluntary and that after given an oral con-
sent they can stop the interview anytime or can skip a
question if they felt they should not answer a particular
question. The participation rate in both surveys was
around 60%. The detailed methodology of the surveys is
described elsewhere [23]. Data on disability and socioeco-
nomic position were collected via face-to-face interviews,
while data on smoking were provided by the participant
through a self-administered questionnaire.
Measures
Disability
The Belgian Health Interview Surveys used the instru-
ments proposed by the WHO-Europe working group to
identify people with disability [24]. Activity restriction is
used to define disability based on four dimensions: diffi-
culties in doing any one of six Activities of Daily Living
(ADL) - transfer in and out of bed, transfer in and out of
chair, dressing, washing of hands and face, feeding, going
to the toilet; or difficulties in mobility; continence prob-
lems; or limitations in sensory (vision, hearing) functions.
Based on the severity of these different dimensions, a vari-
able was constructed with 3 categories: severe disability,
mild disability and no disability (Table 1). For people
younger than 60 years, the functional domain scale of
the SF-36 instrument [25] was used as a filter: (1) a
score of 100 on the scale categorises the respondent as
being not disabled; (2) when the score was less than
100, the disability questions were asked to the respond-
ent, who was then classified as described in Table 1. In
the manuscript we consider disability of all severity
levels (mild and severe) as well as severe disability only.
Smoking
A four-category variable was used: never smokers, ex-
smokers, light smokers (less than 20 cigarette per day) and
heavy smokers (20 cigarettes or more per day).
Socio-economic position
Educational attainment was coded according to the Inter-
national Standard Classification of Education (ISCED 2011)
and was based on the highest level of education reached
by the households’ reference person or his/her partner:
Table 1 Definition of disability by severity
Mild disability Severe disability
Activity of Daily
Living (ADL)
Transfer in and out bed Ability to do the task on his/her own with difficulties Only able to do the task with personal
assistance
Transfer in and out chair
Dressing
Washing of hands and
face
Feeding
Going to the toilet
Mobility Ability to walk less than 200 metres without stopping Ability to walk only a few steps or less without
stopping
Continence Loss of bladder control less than once a month Loss of bladder control at least once a month
Sensorial
functions
Vision Inability, even with glasses, to recognise a friend at a
distance of 4 metres
Inability, even with glasses, to recognise a
friend at a distance of 1 metre
Hearing Inability, even with a hearing aid, to follow a TV
program at a volume others find acceptable
Inability, even with a hearing aid, to follow a TV
program at a volume others find unacceptable
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(ISCED 2), higher secondary education (ISCED 3) and
higher education (ISCED 4–8) [26].
Statistical methods
Mortality and disability
For each subject, the person-years at risk for mortality
were estimated up to the date of death or the end of the
follow-up period. To account for the age changes during
follow-up time, we used Lexis expansions of the original
data with 1 year age-bands [27]. In this procedure, the
observed individual follow-up times were split into periods
that correspond to different current-age (or attained-age)
groups. Therefore, each subject’s person-years of observa-
tion were split into several observations by expanding data
by 1-year age bands. As disability, mortality and smoking
are associated with age and education [16,28,29], we first
estimated mortality rates and disability prevalence rates by
smoking status adjusted for age and education. Poisson
and multinomial logistic regression models were fitted to
estimate the mortality rate and the prevalence of disability
by age, gender and smoking status adjusted for socio-
economic position. Lexis expansion and regression ana-
lysis were performed using Stata 10.0. The analysis
accounted for the complex sampling design of the HIS.
Life table analysis
The age specific mortality rates were used to estimate
LE by gender and smoking category. DFLE and DLE at
age 30 (last open age group: 85 years and plus) and par-
tial DFLE and DLE in the age window 30–80 years
(DFLE30–80 and DLE30–80) were calculated by gender and
smoking category using the Sullivan method which inte-
grates the age-specific disability prevalence into the life
table [30,31]. To estimate the contribution of mortality
and disability to the differences in DFLE and DLE betweensmoking groups, a decomposition method was used
[32,33]. Differences in total life expectancy (LE), DFLE
and DLE between never smokers and other smoking
categories (ex-smokers, smokers, light and heavy smokers)
were divided in two parts. The first component, the mor-
tality effect, represents the differences in the expected
years lived with and without disability due to a differential
mortality experience between never smokers and the other
smoking categories. The second component, the disability
effect, represents the differences in the person-years lived
with or without disability due to differences in the preva-
lence of disability by smoking status. Whereas differences
in LE only reflect differences in mortality rates, differences
in DFLE and DLE are a result of differences in age-specific
mortality rates (mortality effect) and differences in the
age-specific prevalence of disability (disability effect).
Calculations were done using a R 2.14.2 program devel-
oped in the framework of the EHLEIS project [34] and a
copy of the R program is available from W. Nusselder
(w.nusselder@erasmusmc.nl). For the decomposition,
including the variance estimation, the analysis by smok-
ing intensity was only possible for the partial DFLE30–80
and DLE30–80 as there were few very old heavy smoking
females.
Results
Both the prevalence of disability and the mortality rate
are higher in ex-smokers and in light and heavy smokers
compared to never smokers (Tables 2 and 3). As ex-
pected, mortality rates increase with the intensity of
smoking but the relationship between the prevalence of
disability and the intensity of smoking is not as strong,
especially for severe disability. In males, the age and
education adjusted prevalence ratio (a-PR) for disability is
1.17 in ex-smokers, 1.27 in light and 1.34 in heavy smokers,
whilst in females, the a-PR is 1.15 in ex-, 1.22 in light
Table 2 Weighted age and education adjusted (severe) disability prevalence (in %) and prevalence ratio by smoking
status for those aged 30+, Health Interview Survey 1997 and 2001, Belgium
Disability Severe disability
N Prevalence (%) Prevalence ratio Prevalence (%) Prevalence ratio
Males
Never smoker 1667 21.47 1 4.39 1
(19.48; 23.46)* (3.54; 5.25)
Ex-smoker 2325 25.05 1.17 4.41 1.00
(22.86; 27.24) (1.03; 1.33) (3.50; 5.32) (0.76; 1.33)
Light smoker 1262 27.28 1.27 4.92 1.12
(24.65; 29.91) (1.11; 1.45) (3.89; 5.95) (0.84; 1.49)
Heavy smoker 842 28.87 1.34 3.63 0.83
(25.88; 31.86) (1.17; 1.55) (2.72; 4.53) (0.60; 1.13)
Females
Never smoker 3376 26.60 1 5.84 1
(26.17; 27.03) (5.08; 6.59)
Ex-smoker 1665 30.47 1.15 5.76 0.99
(27.80; 33.15) (1.03; 1.28) (4.56; 6.96) (0.77; 1.26)
Light smoker 918 32.58 1.22 6.40 1.10
(27.28; 37.89) (1.03; 1.46) (3.66; 9.14) (0.70; 1.71)
Heavy smoker 548 32.86 1.24 3.88 0.66
(23.35; 42.37) (0.92; 1.66) (0.30; 7.45) (0.26; 1.68)
*: 95% Confidence Interval.
Table 3 Weighted age and education adjusted mortality rate per 100 000 person years and mortality rate ratio by
smoking status for those aged 30+, Health Interview Survey 1997 and 2001 and follow-up until respectively 31/12/
2007 and 31/12/2010, Belgium
Observed deaths Observed person years Mortality rate Mortality rate ratio
Males
Never smoker 188 19618.47 1337.87 1
(1112.97; 1562.77)*
Ex-smoker 541 23129.05 1736.69 1.50
(1562.34; 1911.03) (1.22; 1.84)
Light smoker 277 13791.72 2509.18 1.95
(2073.85; 2944.51) (1.52; 1.84)
Heavy smoker 120 8784.79 3999.89 2.77
(2892.02; 5107.76) (2.00; 3.84)
Females
Never smoker 532 36882.12 871.25 1
(786.18; 956.32)
Ex-smoker 212 17891.89 1076.93 1.09
(917.06; 1236.80) (0.91; 1.30)
Light smoker 73 11000.82 1580.24 1.41
(1091.34; 2069.14) (0.98; 2.02)
Heavy smoker 54 6062.29 2453.82 2.67
(886.06; 4021.57) (1.34; 5.33)
*: 95% Confidence Interval.
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ability is lower, although not reaching statistical signifi-
cance, in heavy smokers (a-PR = 0.83 in males; and 0.66 in
females). The age and education adjusted mortality rate
ratio for ex-, light and heavy smokers is respectively 1.50;
1.95 and 2.77 for males and 1.09; 1.41 and 2.67 for
females.
At age 30 and compared to never smokers, ex-smokers
have a shorter LE and a somewhat shorter DFLE but their
DLE is about one third of a year longer (Table 4). Smokers
have a shorter LE, DFLE and DLE compared to never
smokers. DFLE as a proportion of LE is 74.8% in male
never smokers compared to 72.7% in ex-smokers and
smokers, and 65.8% in female never smokers compared
to 63.6% in ex-smokers and 64.0% in smokers. Both ex-
smokers and smokers are estimated to live fewer years
with severe disability (DLE_S). Table 5 presents the dif-
ference in DFLE, DLE, DLE_S and LE at age 30 be-
tween ex-smokers, smokers and never smokers. A
negative value indicates less years lived compared to
never smokers. Each estimated difference is divided into a
part due to differential age-specific mortality (mortality ef-
fect) and a part that results from a differential age-specific
prevalence of disability (disability effect). Thus, compared
to male never smokers, LE for male smokers is 7.87 years
shorter, this difference in LE being attributable only to the
mortality disadvantage that male smokers have over never
smokers. Male smokers have a shorter DFLE by 6.80 years,
this difference being a result of differences in both the
age-specific mortality rate and age-specific disability
prevalence. The mortality effect accounts for 3.67 years
or 54% of the difference, while the remaining 3.13 yearsTable 4 Disability Free Life Expectancy (DFLE30), (Severe) Disa
and the % of remaining life without disability (% DFLE/LE30)
1997 and 2001 and follow-up until respectively 31/12/2007 a
Smoking status DFLE30 DLE30
Males
Never smoker 38.30 12.89
(36.86; 39.87)* (11.46; 14.71)
Ex-smoker 35.28 13.23
(34.28; 36.27) (12.34; 14.19)
Smoker 31.50 11.82
(30.47; 32.65) (10.76; 12.95)
Females
Never smoker 36.99 19.21
(36.06; 37.90) (18.05; 20.65)
Ex-smoker 34.09 19.52
(32.75; 35.38) (17.93; 21.45)
Smoker 30.73 17.29
(29.12; 32.59) (15.36; 20.52)
*: 95% confidence interval.are due to the higher disability prevalence among smokers.
Due to their disability disadvantage, smokers are expected
to live 3.13 more years with disability but because of the
higher mortality the disability effect is cancelled out result-
ing in 1.07 year shorter DLE compared to never smokers
(−1.07 years = −4.21 years (mortality effect) + 3.13 years
(disability effect)). In both males and females the impact
of the higher mortality among smokers on the DLE out-
weighs the disability effect so that they live fewer years
with disability. This is not the case for DLE of ex-smokers
where the disability effect is larger than the mortality ef-
fect resulting in about one third of a year longer DLE.
Due to a larger mortality effect, both male and female
ex-smokers and smokers live shorter DLE_S, although
the difference is only significant for male smokers.
Figure 1 presents the decomposition by age of (1) the
difference in DFLE and DLE between never smokers and
(ex-)smokers and of (2) the mortality and disability com-
ponent of these differences. The disability effect is the
most important contributor to the shorter DFLE among
ex-smokers up to the age of 84 years (Figure 1a-b) and
up to age 64 years and 74 years for male and female
smokers respectively (Figure 1c-d). For the difference in
DLE between never smokers and (ex-)smokers, the dis-
ability effect is actually outweighed by the mortality ef-
fect only in the older ages: 70+ years and 75+ years for
male and female ex-smokers respectively, and age 65+
years for male and female smokers. For ex-smokers,
the largest proportion (67%) of the disability effect of
DLE difference is concentrated before age 70 years
while for male and female smokers the proportion of
the disability effect before age 70 years is 78% and 73%bility Life Expectancy (DLE(_S)30), Life Expectancy (LE30)
at age 30 by smoking status, Health Interview Survey
nd 31/12/2010, Belgium
DLE_S30 LE30 %DFLE/LE30
3.00 51.19 74.82
(2.17; 4.14) (49.62; 53.10) (71.82; 77.38)
2.42 48.51 72.72
(1.97; 2.87) (47.33; 49.69) (70.97; 74.39)
1.73 43.32 72.72
(1.29; 2.32) (42.27; 44.56) (70.54; 74.82)
5.51 56.20 65.82
(4.78; 6.37) (54.90; 57.71) (63.95; 67.37)
4.53 53.60 63.59
(3.55; 5.91) (51.99; 55.73) (61.05; 66.04)
3.28 48.02 64.00
(2.06; 5.60) (46.31; 51.28) (59.69; 67.43.)
Table 5 Decomposition of the difference between ex- and current smokers with never smokers in Disability Free Life Expectancy (DFLE30), (Severe) Disability
Life Expectancy (DLE(_S)30), Life Expectancy (LE30) at age 30 by type of effect (mortality or disability), Health Interview Survey 1997 and 2001 and follow-up
until respectively 31/12/2007 and 31/12/2010, Belgium
DFLE30 DLE30 DLE_S30 LE30
Smoking
status
Difference Mortality
effect
Disability
effect
Difference Mortality
effect
Disability
effect
Difference Mortality
effect
Disability
effect
Difference Mortality
effect
Disability
effect
Males
Ex-smoker −3.02 −1.13 −1.89 0.34 −1.55 1.89 −0.59 −0.58 −0.01 −2.68 −2.68 0
(−4.87; −1.34)* (−2.13; −0.19) (−3.29; −0.42) (−1.61; 2.08) (−2.89; −0.40) (0.42; 3.29) (−1.77; 0.36) (−1.26; −0.11) (−0.93; 0.80) (−4.88; −0.78) (−4.88; −0.78)
Smoker −6.80 −3.67 −3.13 −1.07 −4.21 3.13 −1.27 −1.38 0.11 −7.87 −7.87 0
(−8.64; −4.96) (−4.84; −2.63) (−4.65; −1.53) (−3.32; 0.87) (−5.78; −2.96) (1.53; 4.65) (−2.49; −0.23) (−2.30; −0.82) (−0.92; 1.10) (−10.27; −5.35) (−10.27; −5.35)
Females
Ex-smoker −2.90 −0.74 −2.16 0.31 −1.85 2.16 −0.98 −0.84 −0.14 −2.59 −2.59 0
(−4.46; −1.29) (−1.49; −0.04) (−3.62; −0.12) (−1.82; 2.62) (−3.49; −0.12) (0.63; 3.62) (−2.24; 0.48) (−1.66; 0.10) (−1.31; 1.09) (−4.69; −0.36) (−4.69; −0.36)
Smoker −6.25 −2.49 −3.77 −1.92 −5.69 3.77 −2.23 −2.43 0.19 −8.17 −8.17 0
(−8.17; −4.24) (−3.67; −1.45) (−5.78; −1.50) (−4.30; 1.27) (−7.41; −3.06) (1.50; 5.78) (−3.85; 0.26) (−3.72; −1.00) (−1.89; 2.55) (−10.40; −4.86) (−10.40; −4.86)
*: 95% confidence interval.
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Figure 1 Decomposition by age of the difference between ex- and current smokers with never smokers in Disability Free Life Expectancy
(DFLE30), Disability Life Expectancy (DLE30) at age 30 and type of effect (mortality or disability), Health Interview Survey 1997 and 2001 and
follow-up until respectively 31/12/2007 and 31/12/2010, Belgium. Legend: Panels a-d: DFLE (a: Male Ex-smoker; b: Female Ex-smoker; c: Male
Smoker; d: Female Smoker). Panels e-h: DLE (e: Male Ex-smoker; f: Female Ex-smoker; g: Male Smoker; h: Female Smoker). Black bar: difference DFLE or
DLE with never smokers. Green bar: mortality effect. Red bar: disability effect. E.g. black bar in panel a: DFLE among males Ex-smokers minus DFLE
among males never smokers; black bar in panel h: DLE among females Ex-smokers minus DLE among females never smokers.
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Table 6 Disability Free Life Expectancy (DFLE30–80), (Severe) Disability Life Expectancy (DLE(_S)30–80), Life Expectancy
(LE30–80) and the % of remaining life without disability (% DFLE/LE30–80) between ages 30 and 80 by smoking status,
Health Interview Survey 1997 and 2001 and follow-up until respectively 31/12/2007 and 31/12/2010, Belgium
Smoking status DFLE30–80 DLE30–80 DLE_S30–80 LE30–80 % DFLE/LE30–80
Males
Never smoker 36.38 9.46 1.52 45.84 79.37
(35.22; 37.54)* (8.37; 10.59) (1.06; 2.04) (44.97; 46.62) (76.93; 81.65)
Ex-smoker 34.06 10.68 1.47 44.74 76.13
(33.09; 35.01) (9.90; 11.48) (1.17; 1.82) (43.84; 45.56) (74.39; 77.79)
Smokers 30.85 10.72 1.38 41.58 74.21
(29.87; 31.88) (9.76; 11.58) (0.97; 1.80) (40.66; 42.19) (72.24; 76.36)
Light smoker 31.80 10.90 1.56 42.70 74.46
(30.53; 33.05) (9.82; 12.01) (1.09; 2.09) (41.55; 43.82) (71.96; 76.86)
Heavy smoker 29.35 10.28 0.98 39.63 74.06
(27.53; 31.23) (8.70; 11.94) (0.39; 1.78) (38.16; 41.10) (70.09; 78.01)
Females
Never smoker 34.77 12.47 2.22 47.23 73.60
(33.97; 35.49) (11.82; 13.25) (1.87; 2.58) (46.70; 47.75) (72.02; 74.91)
Ex-smoker 32.48 14.08 2.15 46.57 69.76
(31.35; 33.56) (12.98; 15.23) (1.67; 2.65) (45.76; 47.32) (67.38; 71.97)
Smokers 29.98 14.30 2.02 44.28 67.70
(28.66; 31.50) (12.79; 15.60) (1.35; 2.75) (43.27; 45.33) (64.85; 71.02)
Light smoker 30.90 14.27 2.22 45.17 68.40
(29.19; 32.61) (12.53; 16.01) (1.43; 3.10) (43.91; 46.46) (64.83; 72.15)
Heavy smoker 28.41 14.27 1.52 42.68 66.56
(25.77; 31.25) (11.54; 17.29) (0.56; 3.09) (40.73; 44.65) (60.22; 72.71)
*: 95% confidence interval.
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of the disability disadvantage to the longer DLE in ex-
smokers, smokers, light smokers and heavy smokers is fur-
ther shown by the decomposition of the difference in the
partial DLE in the age window 30 to 80 years (DLE30–80)
(Tables 6, Figure 2). Within this age window, any smoking
category experiences more years with disability compared
to never smokers, as the disability effect cancels out the
mortality effect. For example, the difference in DLE30–80
among male ex-smokers compared to never smokers is
1.22 years (1.22 years (95% CI: −0.04; 2.62) = −0.45 years
(mortality effect) + 1.67 (disability effect)). The difference
with smokers is 1.27 years (95% CI: −0.13; 2.57). We ob-
serve a larger difference among light males smokers
(1.45 years (95% CI: −0.02; 2.90)) compared to difference
among heavy smokers (0.82 years (95% CI: −1.15; 3.01))
suggesting a larger contribution of the mortality effect
for heavy smokers even before age 80 years old. The
difference in DLE30–80 among female ex-smokers,
smokers, light and heavy smokers compared to never
smokers is respectively 1.62 years (95 CI; 0.26; 2.88),1.83 years (95 CI; 0.13; 3.35), 1.80 years (95 CI; −.0.09;
3.78) and 1.80 years (95 CI; −0.90; 4.90). Restricting the
analysis to severe disability, the mortality effect by far
outweighs any disability effect and is the most import-
ant contributor to shorter DLE_S30–80 in any age group.
None of the differences in DLE_S30–80 for the different
smoking categories compared to never smokers is sta-
tistically significant (Figure 2).
Discussion
The study confirms that smoking kills but also shows that
smoking increases the years lived with disability before age
80 years old, while at older ages, the excess mortality of
smokers hides the smoker disability disadvantage. In other
words, through the excess premature mortality of
smokers, their DLE is shorter compared to never smokers.
When the intensity of smoking is high, the excess mortal-
ity hides the disability disadvantage in DLE even before
age 80. Our study also shows that ex-smokers have a
shorter DFLE and a longer DLE. The disability disadvan-
tage that ex-smokers have is the main contributor to the
Figure 2 Decomposition of the difference between ex- and current smokers with never smokers in Disability Free Life Expectancy
(DFLE30–80), (Severe) Disability Life Expectancy (DLE(_S)30–80) between ages 30 and 80 by type of effect (mortality or disability), Health
Interview Survey 1997 and 2001 and follow-up until respectively 31/12/2007 and 31/12/2010, Belgium. Legend: Black dot symbol:
difference DFLE, DLE or DLE_S with never smoker and 95% CI. Green triangle symbol: mortality effect and 95% CI. Red letter x symbol: disability
effect and 95% CI.
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smokers, even though mortality rates for ex-smokers may
approach those for never smokers. At older ages, as for
smokers, the excess mortality offsets the disability dis-
advantage but this occurs at an older age than for smokers.So at the one hand, the observations support the expan-
sion hypothesis: in the end smokers may live less years
with disability due to their strong excess mortality. At the
other hand, ex-smokers and smokers have to endure more
years with disability before age 80 years. These seemingly
Van Oyen et al. BMC Public Health 2014, 14:723 Page 10 of 12
http://www.biomedcentral.com/1471-2458/14/723two opposing observations are a result of the fact that the
expression of the difference in disability prevalence are
concentrated at the younger ages, while the strength of
smoking related mortality disadvantage is greater at older
ages and reduces the years to be lived with and without
disability. Moreover, the interaction between excess mor-
tality and excess disability is further a function of gender,
smoking intensity and the severity level of the disability.
The expression of the disability effect is somewhat higher
in women for whom lower premature excess mortality re-
duces DLE less than for men. The female–male difference
in the mortality and disability impact of smoking may be a
contributing factor to the gender health-survival paradox
[35]. Our study also suggests a significantly shorter LE free
of severe disability (DFLE_S) for male heavy smokers com-
pared to never smokers.
Overall, our study does support the statement that
smoking is associated with mortality more than with dis-
ability, and that through excess mortality the years of life
with disability are compressed compared to never smokers
[15-17]. However the findings also partly corroborate pre-
vious reports [18-20] suggesting that smoking has an im-
portant and distinct impact on disability which results in
more years with disability at younger ages for ex-smokers
and smokers. Other studies on the effect of smoking have
also reported an increased incidence of disability, a lower
(physical) health related quality of life and an elevated use
of health care services [11,12,36-39].
Our analysis has several strengths. We were able to use
one data set which had smoking, disability and mortality
data. For the mortality follow-up of the survey, less than 3%
of the participants could not be linked to the National
Register. Our decomposition analysis allowed division of
the differences in DFLE and DLE into the part due to
excess mortality for (ex-)smokers and the part due to their
excess disability, as well as how these varied by age group.
This therefore helped explain the controversy that longer
LE for non-smokers compared to (ex-)smokers translates
into more years of disability. To obtain further insight we
evaluated in which age groups the mortality effect or
the disability effect were more substantial. To our
knowledge, this paper is the first to show the excess
disability associated with smoking contributing to
more years with disability at younger ages.
Limitations of the study are related to the cross-
sectional design providing the smoking and disability
data. E.g. current smokers at any age after the age of
30 years may be considered as lifelong smokers as the
likelihood of smoking initiation after the age of 30 years
is small. If we ignore non-successful smoke stop at-
tempts, the category “current smoker” is probably a less
heterogeneous population compare to the category of
ex-smokers for whom no information on the age or the
time since they stop smoking and their reasons to stopsmoking is used: health benefits are larger in early quitters
while former smokers who recently quit tend to have
more health problems [6,36]. Further, we cannot attribute
the lower prevalence of disability (which led among never
smokers to more healthy years and to a reduction in the
time spent with disability before age 80) to either a lower
disability incidence or a higher recovery rate since this is
beyond the decomposition method using Sullivan method
based estimates [33]. The main assumption of stationary
population in order to minimise bias of the Sullivan
method compared to the multistate life table method
using transition probability may hold as changes in
smoking behaviour do not lead to sudden changes in
both mortality incidence and disability incidence [40].
It is difficult to identify to what extend the method
used to estimate the years lived with and without dis-
ability contributes to the lack of agreement related to
the compression of disability in function of smoking
elimination. Some authors include both transitions to
disability and recovery [14,16,20] in the multistate
method, others do not [17]. Next, studies differ further
in definition of disability, the definition of smoking cat-
egories. Studies also studies differ in the age the DFLE
and LE is estimated. The paper of Nusselder et al. [20],
is the only one using the multistate method, including
both disability incidence and recovery transitions, that
provides evidence for a compression of years with dis-
ability related to smoking elimination both at age 30
and at age 70 years. The same conclusion was made by
Bronnum-Hansen et al. using the Sullivan method [19].
Other studies using a multistate approach report that
smoking reduces both the duration of life with and
without disability [14,16,17].
Secondly, low survey participation may bias the results
[41]. We have shown in prior studies that participation is
differentially linked to health status and socioeconomic
position [42,43]. Charafedinne R. et al. [44] compared
Belgian census-based DFLE by social position with
survey-based estimates and found that although there
was no statistical difference, the difference in LE and
DFLE should be acknowledged. Low educated survey
participants tended to be less healthy (i.e. having a lower
LE and lower DFLE) compared to their counterparts in
the general population, while the inverse was observed
in the highest educational groups. The same author also
reported evidence supporting the hypothesis that edu-
cational attainment does not substantially influence the
association between smoking and mortality [28]. There-
fore, we hypothesize that any selection bias in the differ-
ence in DFLE or DLE by smoking is most likely related
to the survey-based disability prevalence and not to the
mortality. If any, it is expected to overestimate the gap
and the disability effect of the smoking related differ-
ences in DFLE and DLE.
Van Oyen et al. BMC Public Health 2014, 14:723 Page 11 of 12
http://www.biomedcentral.com/1471-2458/14/723Other limitations are related to the validity of survey
data. The validity of self-reported smoking can be ques-
tioned, although a number of studies have found the valid-
ity of this self-reporting high [45]. However we expect that
any misclassification of smoking status would result in
underestimation of the reported differences. A final im-
portant limitation is related to the delay in coding causes
of mortality in Belgium. We were not able to estimate the
contribution of specific diseases to the differences in DFLE
and DLE by smoking status. This limits the interpretation
on the role of specific diseases interfering with the balance
between the smoking related excess of mortality and the
smoking related disability.Conclusion
We were able to evaluate the contribution of the excess
mortality versus the disabling impact of tobacco exposure
on population health. Smoking kills and shortens both life
without and with disability mainly due to its related excess
mortality. However excess disability associated with smok-
ing cannot be ignored given its contribution to substan-
tially more years with disability before age 80.
The important population health message remains:
smoking is a major health hazard. Policy on smoking
should strive for a smoke-free society through primor-
dial prevention or reduction of smoking initiation and
through primary prevention or smoke stop to increase
LE and DFLE. Further, given the lack of compression of
disability for never smokers compared to smokers, this
study highlight the need for policy makers to monitor
not only DFLE (e.g. the European Union 2020 health
goal to increase the healthy and active ageing of the
European population by 2 years [46]) but also DLE as
reduction in health risks and the increase in DFLE, may
not automatically result in a simultaneous reduction or
status quo of the DLE.
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